Literature DB >> 26944216

The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design.

Daniel Watterson1, Naphak Modhiran1, Paul R Young2.   

Abstract

The flavivirus non-structural protein, NS1, is an unusual viral gene product. Despite the recent unveiling of its atomic structure (Akey et al., 2014), and a growing list of host molecules with which it has been found associated, the primary function of NS1 remains elusive. It assumes many diverse roles including direct participation in the flaviviral replication complex and virion maturation. In its secreted form it is a hexameric lipoparticle that is involved in systemic immune and endothelial cell modulation. In this review we highlight recent advances in elucidating the molecular mechanisms underpinning NS1 function and present the current state of play and some future prospects for NS1 targeted antiviral strategies. This article forms part of a symposium on flavivirus drug discovery in Antiviral Research.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antiviral; Complement; Dengue; Flavivirus; Inhibitors

Mesh:

Substances:

Year:  2016        PMID: 26944216     DOI: 10.1016/j.antiviral.2016.02.014

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  42 in total

1.  Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.

Authors:  Anzhong Li; Miaoge Xue; Zayed Attia; Jingyou Yu; Mijia Lu; Chao Shan; Xueya Liang; Thomas Z Gao; Pei-Yong Shi; Mark E Peeples; Prosper N Boyaka; Shan-Lu Liu; Jianrong Li
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Genome-Wide Mutagenesis of Dengue Virus Reveals Plasticity of the NS1 Protein and Enables Generation of Infectious Tagged Reporter Viruses.

Authors:  Nicholas S Eyre; Stephen M Johnson; Auda A Eltahla; Maria Aloi; Amanda L Aloia; Christopher A McDevitt; Rowena A Bull; Michael R Beard
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

3.  Zika virus NS1, a pathogenicity factor with many faces.

Authors:  Rolf Hilgenfeld
Journal:  EMBO J       Date:  2016-10-27       Impact factor: 11.598

Review 4.  Using Macaques to Address Critical Questions in Zika Virus Research.

Authors:  Dawn M Dudley; Matthew T Aliota; Emma L Mohr; Christina M Newman; Thaddeus G Golos; Thomas C Friedrich; David H O'Connor
Journal:  Annu Rev Virol       Date:  2019-06-10       Impact factor: 10.431

5.  Orally Administrable Therapeutic Synthetic Nanoparticle for Zika Virus.

Authors:  Bapurao Surnar; Mohammad Z Kamran; Anuj S Shah; Uttara Basu; Nagesh Kolishetti; Sapna Deo; Dushyantha T Jayaweera; Sylvia Daunert; Shanta Dhar
Journal:  ACS Nano       Date:  2019-10-11       Impact factor: 15.881

Review 6.  Promiscuous viruses-how do viruses survive multiple unrelated hosts?

Authors:  Gregory D Ebel
Journal:  Curr Opin Virol       Date:  2017-05-31       Impact factor: 7.090

Review 7.  Secretion of Nonstructural Protein 1 of Dengue Virus from Infected Mosquito Cells: Facts and Speculations.

Authors:  Ana C Alcalá; Laura A Palomares; Juan E Ludert
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

8.  Extended surface for membrane association in Zika virus NS1 structure.

Authors:  W Clay Brown; David L Akey; Jamie R Konwerski; Jeffrey T Tarrasch; Georgios Skiniotis; Richard J Kuhn; Janet L Smith
Journal:  Nat Struct Mol Biol       Date:  2016-07-25       Impact factor: 15.369

Review 9.  Monoclonal Antibodies against Zika Virus: Therapeutics and Their Implications for Vaccine Design.

Authors:  Qihui Wang; Jinghua Yan; George Fu Gao
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

10.  Structural Study of the C-Terminal Domain of Nonstructural Protein 1 from Japanese Encephalitis Virus.

Authors:  Thanalai Poonsiri; Gareth S A Wright; Michael S Diamond; Lance Turtle; Tom Solomon; Svetlana V Antonyuk
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.